H. Kukko et E. Halmesmaki, Prenatal care and counseling of female drug-abusers: effects on drug abuseand perinatal outcome, ACT OBST SC, 78(1), 1999, pp. 22-26
Background. To evaluate the efficacy of a specific counseling and withdrawa
l program for drug-abusing pregnant women and its effect on perinatal outco
me.
Design and setting. An analysis of 120 pregnancies-followed in 111 drug-abu
sing women giving birth at the Department of Obstetrics and Gynecology, Hel
sinki University Central Hospital, in 1985-95.
Methods. personnel responsible for local maternity care in the Helsinki are
a were trained to identify pregnant drug-abusers and to refer them to our h
ospital for clinical antenatal carl and counseling with psychological and s
ocial support. Substance abuse during pregnancy was monitored by self-repor
t and serial urine screenings. Obstetric and perinatal outcome were compare
d between those who succeeded in quitting totally or reducing drug use, and
those who continued their drug use throughout pregnancy. The significance
of the differences was tested by Student's unpaired t-test and binomial t-t
est.
Results. Of the women, 62% registered before the 20th week of pregnancy and
32% during the 20th-29th week of pregnancy (mean 18.4+/-6.6 weeks). Twelve
women were admitted to an obstetric ward for withdrawal. In 73 of the 120
(61%) pregnancies the woman succeeded either in quitting totally or reducin
g drug abuse. Among this group, incidence of preterm birth (4.1%) was small
er (p<0.001), and gestational age (39.8+/-2.2 weeks) and birth weight (3393
+/-605 gr) higher (p<0.05) than those (19.6%, 38.3+/-3.4 wk and 3049+/-728
gr, respectively) in the group continuing their drug abuse. Additionally, t
he percentage of normal delivery (80.8%) was higher (p<0.05), and incidence
of withdrawal symptoms (19.2%), lower (p<0.001) than for those who continu
ed drug abuse (65.2% and 47.8%, respectively).
Conclusions. Carefully monitored counseling program for pregnant drug abuse
rs is effective in reducing the amount of drugs used and improves perinatal
outcome.